{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:55:07Z","timestamp":1792086907387,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Martin-Leo Hansmann for many helpful discussions"},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["KU1315\/7-1"],"award-info":[{"award-number":["KU1315\/7-1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["GRK1431\/2"],"award-info":[{"award-number":["GRK1431\/2"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.semcancer.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T04:45:26Z","timestamp":1464065126000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["NF-\u03baB deregulation in Hodgkin lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Marc A.","family":"Weniger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2016.05.001_bib0005","series-title":"Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0010","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0952-7915(97)80145-8","article-title":"Mechanisms of selection and differentiation in germinal centers","volume":"9","author":"Liu","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0025","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1182\/blood-2003-12-4291","article-title":"Tracking CD40 signaling during germinal center development","volume":"104","author":"Basso","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0030","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1182\/blood.V87.10.4340.bloodjournal87104340","article-title":"High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin\/Reed-Sternberg cells","volume":"87","author":"Bargou","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0035","first-page":"3353","article-title":"Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells","volume":"52","author":"Gruss","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.onc.1202351","article-title":"Molecular mechanisms of constitutive NF-kappaB\/Rel activation in Hodgkin\/Reed-Sternberg cells","volume":"18","author":"Krappmann","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0050","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2004-09-3620","article-title":"Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas","volume":"106","author":"Mathas","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0055","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.onc.1201735","article-title":"Defective I\u03baB\u03b1 in Hodgkin cell lines with constitutively active NF-\u03baB","volume":"16","author":"Wood","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0060","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0065","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-08-2577","article-title":"Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma","volume":"101","author":"Barth","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/modpathol.3880306","article-title":"Characterization of NF-\u03baB expression in Hodgkin's disease: inhibition of constitutively expressed NF-\u03baB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells","volume":"14","author":"Izban","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.pas.0000149689.75462.ff","article-title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas","volume":"29","author":"Rodig","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0080","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.molimm.2009.05.178","article-title":"TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells","volume":"46","author":"Guo","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0085","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/sj.onc.1208564","article-title":"Aberrant NF-kappaB2\/p52 expression in Hodgkin\/Reed-Sternberg cells and CD30-transformed rat fibroblasts","volume":"24","author":"Nonaka","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0090","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0280-5","article-title":"A roadmap of constitutive NF-kB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses","volume":"8","author":"de Oliveira","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0100","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2012-01-405951","article-title":"Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival","volume":"120","author":"Ranuncolo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0105","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1182\/blood-2007-09-110635","article-title":"Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells","volume":"111","author":"Saitoh","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0110","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed-Sternberg cells","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.20020062","article-title":"Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity","volume":"196","author":"Hinz","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V99.4.1109","article-title":"Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs","volume":"99","author":"H\u00f6pken","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2015.127498","article-title":"Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis","volume":"100","author":"Wein","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease","volume":"114","author":"Molin","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0145","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/blood.V88.9.3299.bloodjournal8893299","article-title":"Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line","volume":"88","author":"Pinto","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.4306","article-title":"Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma","volume":"232","author":"Hansen","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0155","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0002-9440(10)61112-1","article-title":"Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells","volume":"160","author":"Horie","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0160","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood.V96.13.4307","article-title":"Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells","volume":"96","author":"Mir","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0165","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1074\/jbc.M608817200","article-title":"CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells","volume":"282","author":"Wright","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V85.3.780.bloodjournal853780","article-title":"Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines","volume":"85","author":"Carbone","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0180","first-page":"21","article-title":"CD40 expression in Hodgkin's disease","volume":"144","author":"O'Grady","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0185","first-page":"912","article-title":"CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease","volume":"147","author":"Carbone","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood.V96.8.2841","article-title":"Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor","volume":"96","author":"Annunziata","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0195","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","article-title":"Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL","volume":"109","author":"Chiu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0200","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.leu.2404627","article-title":"Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's disease","volume":"21","author":"Schwaller","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: T cells, bone loss, and mammalian evolution","volume":"20","author":"Theill","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0210","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V98.9.2784","article-title":"Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines","volume":"98","author":"Fiumara","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.humpath.2005.08.005","article-title":"BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders","volume":"36","author":"Rodig","year":"2005","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0220","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/sj.onc.1202893","article-title":"Mutations in the I\u03baB\u03b1 gene in Hodgkin's disease suggest a tumour suppressor role for I\u03baB\u03b1","volume":"18","author":"Cabannes","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0225","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V94.9.3129","article-title":"Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells","volume":"94","author":"Emmerich","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkBa gene in the malignant cells in Hodgkin's disease","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0240","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/1471-2407-12-457","article-title":"Deletion of the TNFAIP3\/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma","volume":"12","author":"Nomoto","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0250","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cancergencyto.2009.11.005","article-title":"Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma","volume":"197","author":"Liu","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0260","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/gcc.20789","article-title":"Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma","volume":"49","author":"Schmidt","year":"2010","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0265","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ijc.24502","article-title":"Mutations of NFKBIA, encoding IkappaBalpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases","volume":"125","author":"Lake","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0270","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1097-0215(20010601)92:5<678::AID-IJC1259>3.0.CO;2-R","article-title":"Chromosome 16q deletion and loss of E-cadherin expression in Hodgkin and Reed-Sternberg cells","volume":"92","author":"Ohshima","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0275","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2141.2012.09113.x","article-title":"Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma","volume":"157","author":"Otto","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0280","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2","volume":"99","author":"Joos","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0285","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0290","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0295","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","article-title":"Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization","volume":"93","author":"Hartmann","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0300","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.696","article-title":"A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)","volume":"42","author":"Enciso-Mora","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-09-3843","article-title":"Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma","volume":"108","author":"Martin-Subero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cancergencyto.2008.06.007","article-title":"BCL2 and BCL3 are recurrent translocation partners of the IGH locus","volume":"186","author":"Szymanowska","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0320","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/gcc.22331","article-title":"Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma","volume":"55","author":"Salipante","year":"2016","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0325","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0330","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0335","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molimm.2014.06.013","article-title":"Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin beta receptor (LTbetaR) in human cells stimulated by the shared ligand LIGHT","volume":"62","author":"Bechill","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2009.010157","article-title":"Mutations in the genes coding for the NF-kappaB regulating factors IkappaBalpha and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"95","author":"Schumacher","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0345","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.13310","article-title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma","volume":"169","author":"Hartmann","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0350","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1- positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0355","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0360","first-page":"549","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain","volume":"10","author":"Huen","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0365","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor","volume":"17","author":"Kilger","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0370","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin's disease","volume":"16","author":"K\u00fcppers","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0375","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","article-title":"Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas","volume":"106","author":"Bechtel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0380","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of crippled germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0385","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1182\/blood-2005-06-2327","article-title":"Epstein-Barr virus infection in vitro can resue germinal centre B cells with inactivated immunoglobulin genes","volume":"106","author":"Chaganti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0390","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"K\u00fcppers","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0395","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin and Reed\/Sternberg cells in Hodgkin's lymphoma","volume":"118","author":"Br\u00e4uninger","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0400","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0405","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri2998","article-title":"Expanding TRAF function: TRAF3 as a tri-faced immune regulator","volume":"11","author":"Hacker","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0410","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni1421","article-title":"Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production","volume":"8","author":"Gallagher","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0415","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0420","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","article-title":"Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B","volume":"21","author":"Mathas","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0425","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1158\/0008-5472.CAN-05-0925","article-title":"JunB induced by constitutive CD30-extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma","volume":"65","author":"Watanabe","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0430","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humpath.2013.10.024","article-title":"c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma","volume":"45","author":"Leventaki","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0435","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.pas.0000213412.25935.e4","article-title":"c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders","volume":"31","author":"Drakos","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0440","first-page":"3485","article-title":"Receptor activator of nuclear factor-kB ligand activates mitogen-activated protein kinases signaling pathways in hodgki and reed-Sternberg cells","volume":"99","author":"Mukhopadhyay","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbrc.2011.06.157","article-title":"Involvement of Cot activity in the proliferation of ALCL lymphoma cells","volume":"411","author":"Fernandez","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0450","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/JVI.76.9.4567-4579.2002","article-title":"The oncogenic protein kinase Tpl-2\/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2","volume":"76","author":"Eliopoulos","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0455","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2010-01-265827","article-title":"Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed\/Sternberg cells","volume":"116","author":"Stanelle","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0460","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/leu.2011.265","article-title":"Notch is an essential upstream regulator of NF-kappaB and is relevant for survival of Hodgkin and Reed-Sternberg cells","volume":"26","author":"Schwarzer","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0465","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","article-title":"Pathogenetic importance and therapeutic implications of NF-kappaB in lymphoid malignancies","volume":"246","author":"Lim","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-269-8_1","article-title":"Origin and pathogenesis of B cell lymphomas","volume":"971","author":"Seifert","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0475","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2005-09-3765","article-title":"Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma","volume":"107","author":"Ushmorov","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0480","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow-sorting and exome sequencing reveals the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0485","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/sj.leu.2403129","article-title":"Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?","volume":"17","author":"Martin-Subero","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0490","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-2141.2002.03894.x","article-title":"An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591","volume":"119","author":"Vockerodt","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0495","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood.V87.8.3429.bloodjournal8783429","article-title":"Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin\/Reed-Sternberg cells of a Hodgkin's lymphoma patient","volume":"87","author":"Kanzler","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0500","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3324\/haematol.11073","article-title":"A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines","volume":"92","author":"Feys","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0505","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1002\/ijc.27416","article-title":"Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas","volume":"131","author":"Scholtysik","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.05.001_bib0510","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2141.2008.07262.x","article-title":"Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines","volume":"142","author":"Giefing","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.05.001_bib0515","unstructured":"K\u00fcppers R., 2011, Biology of Hodgkin's lymphoma. Hematology Education: the education programme for the annual congress of the European Hematology Association 5, 151-157."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T22:24:32Z","timestamp":1718576672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X16300190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":103,"alternative-id":["S1044579X16300190"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.05.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NF-\u03baB deregulation in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}